Skip to main content
. 2020 Aug 17;21(16):5904. doi: 10.3390/ijms21165904

Figure 1.

Figure 1

Comparisons of dysregulated miRNAs in brain and body fluid samples of ASD patients. (a) Summary of the up-regulated miRNA expression in four different regions of the brain. The four brain regions are the cerebellar cortex (BA 9) [24], frontal cortex (BA 10) [68], temporal lobe [92], and cerebellum [103]. (b) Summary of the down-regulated miRNA expression in four different brain tissues. The four brain tissues are the cerebellar cortex (BA 9) [24], frontal cortex (BA 10) [68], cerebellum [103], and STS + PAC (BA 22/41/42) [104]. (c) Summary of the up-regulated miRNAs in two peripheral blood, one serum [73], and three lymphoblastoid cell line (LCL) sample sets, and the two peripheral blood sample sets in the figure are divided into peripheral blood No. 1 [70], and peripheral blood No. 2 [107], and the three LCL sample sets are divided into LCL No. 1 [58], LCL No. 2 [59], and LCL No. 3 [106]. (d) Summary of the down-regulated miRNAs in two peripheral blood, one serum [105], and one LCL [58] sample sets, and the two peripheral blood sample sets are divided into peripheral blood No. 1 [70], and peripheral blood No. 2 [107]. (e) A comparison of up-regulated miRNAs in two sets of salivary samples of ASD, and the two saliva sample sets are divided into saliva No. 1 [109], and saliva No. 2 [110].